Home › Funds › Bracebridge Capital, LLC › ALVO
Bracebridge Capital, LLC position in ALVO
ALVOTECH · Health Care
Bracebridge Capital, LLC reported holding 4,038,637 shares of ALVO (ALVOTECH) in its Q2 2026 13F filing — a position valued at US$14.9M, representing 3.77% of its reported portfolio and ranking #8 among its reported holdings. Bracebridge Capital, LLC has disclosed ALVO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Bracebridge Capital, LLC's ALVO position evolved
Bracebridge Capital, LLC first disclosed a stake in ALVO in Q3 2023 at 4,360,524 shares (US$39.77B). The position peaked in Q4 2023 at 4,360,524 shares, worth US$50.06B. Across 12 filings, Bracebridge Capital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 4,038,637 shares valued at US$14.9M — an increase of 1,333,333 shares quarter over quarter.. Notable position changes include a 38% trim in Q1 2024 (shares were roughly flat over the following quarter), a 49% increase in Q2 2026 (shares rose 57% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.36M | $39.77B | New |
| Q4 2023 | 4.36M | $50.06B | Hold |
| Q1 2024 | 2.71M | $33.06B | Reduce |
| Q2 2024 | 2.71M | $32.90B | Hold |
| Q3 2024 | 2.71M | $32.19M | Hold |
| Q4 2024 | 2.71M | $35.79M | Hold |
| Q1 2025 | 2.71M | $26.16M | Hold |
| Q2 2025 | 2.71M | $24.67M | Hold |
| Q3 2025 | 2.71M | $22.16M | Hold |
| Q4 2025 | 2.71M | $13.88M | Hold |
| Q1 2026 | 2.71M | $9.28M | Hold |
| Q2 2026 | 4.04M | $14.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALVO and 13F data
ALVO (ALVOTECH) is a Health Care company. 38 other funds we track also report a position in ALVO — the largest reported positions include LITTLEJOHN & CO LLC (US$4.9M), Ulland Investment Advisors, LLC (US$667K), Oaktree Capital Management (US$281K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALVO
- LITTLEJOHN & CO LLC 1.32M sh · $4.87M · Q2 2026
- Ulland Investment Advisors, LLC 115.00K sh · $667.00K · Q3 2026
- Oaktree Capital Management 76.02K sh · $280.52K · Q2 2026
More on Bracebridge Capital, LLC
FAQ
How long has Bracebridge Capital, LLC held ALVO?
Bracebridge Capital, LLC has disclosed ALVO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Bracebridge Capital, LLC's current position in ALVO?
As of Q2 2026, Bracebridge Capital, LLC holds 4.04M shares of ALVO (ALVOTECH), valued at $14.90M, representing 3.77% of its reported portfolio and ranking #8.
Has Bracebridge Capital, LLC been buying or selling ALVO?
In the latest 13F filing (Q2 2026), Bracebridge Capital, LLC increased its position in ALVO. The position peaked in Q4 2023 at 4.36M shares.
Which other funds hold ALVO?
Other major institutional holders of ALVO include LITTLEJOHN & CO LLC, Ulland Investment Advisors, LLC, Oaktree Capital Management, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.